Implications of Mineralization Biomarkers in Breast Cancer Outcomes Beyond Calcifications
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26020645 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Erica Giacobbi und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental Medicine, TOR, University of Rome "Tor Vergata", 00133 Rome, Italy. Hauptthemen laut MEDLINE: Breast Neoplasms, Biomarkers, Tumor, Calcinosis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero dell'Università e della Ricerca PRIN2022, “Ministero dell’Università e della Ricerca” PRIN2022.
Abstract (Originalsprache)
The aim of this work was to explore the biomarkers associated with epithelial to mesenchymal transition (EMT) and mineralization processes as new prognostic factors across different breast cancer phenotypes. To this end, 133 breast biopsies, including benign and malignant lesions, with or without microcalcifications, were retrospectively collected. Immunohistochemical analysis was performed to evaluate the expression of vimentin, BMP-2, BMP-4, RANKL, Runx2, OPN, PTX3, and SDF-1, while Kaplan—Meier plots were used to assess their prognostic impact on overall survival in a dataset of 2976 breast cancer patients. The expression of vimentin, BMP-2, BMP-4, and SDF-1 was significantly higher in malignant lesions compared to benign ones, regardless of the presence of microcalcifications. Notably, these markers showed no correlation with traditional prognostic factors, such as tumor grade or hormone receptor status. The bioinformatics analysis provided valuable insights into the possible prognostic and therapeutic significance of BMP-2, BMP-4, SDF-1, and vimentin in breast cancer. In fact, all these biomarkers impact on the overall survival in specific molecular breast cancer types. In addition, high expression of SDF-1 and vimentin is able to predict the response to chemotherapy. The findings here reported suggest that vimentin, BMP-2, BMP-4, and SDF-1 could be independent prognostic biomarkers in breast cancer, providing insights beyond traditional clinical factors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Experimental Medicine, TOR, University of Rome "Tor Vergata", 00133 Rome, Italy.
- Breast Unit, Department of Surgical Science, University of Rome "Tor Vergata", 00133 Rome, Italy.
ORCID-Profile: Erica Giacobbi, Gabriele Rotondaro, Francesca Servadei, Alessandro Mauriello, Manuel Scimeca
Förderung
- Ministero dell'Università e della Ricerca PRIN2022
- “Ministero dell’Università e della Ricerca” PRIN2022
Zitieren
APA
Giacobbi, E., Bonfiglio, R., Rotondaro, G., Servadei, F., Smirnov, A., Palumbo, V., Scioli, M. P., Bonanno, E., Buonomo, C. O., Vanni, G., Candi, E., Mauriello, A., & Scimeca, M. (2025). Implications of Mineralization Biomarkers in Breast Cancer Outcomes Beyond Calcifications. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26020645
Vancouver
Giacobbi E, Bonfiglio R, Rotondaro G, Servadei F, Smirnov A, Palumbo V, et al. Implications of Mineralization Biomarkers in Breast Cancer Outcomes Beyond Calcifications. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26020645
BibTeX
@article{Giacobbi2025,
author = {Giacobbi, Erica and Bonfiglio, Rita and Rotondaro, Gabriele and Servadei, Francesca and Smirnov, Artem and Palumbo, Valeria and Scioli, Maria Paola and Bonanno, Elena and Buonomo, Claudio Oreste and Vanni, Gianluca and Candi, Eleonora and Mauriello, Alessandro and Scimeca, Manuel},
title = {Implications of Mineralization Biomarkers in Breast Cancer Outcomes Beyond Calcifications},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26020645}
}
EUVIMED